Leidos (NYSE:LDOS – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Saturday.
A number of other brokerages have also weighed in on LDOS. Argus upgraded Leidos to a “strong-buy” rating in a research note on Tuesday, March 31st. Truist Financial lowered their price objective on Leidos from $220.00 to $195.00 and set a “buy” rating for the company in a research note on Monday, April 20th. Citigroup lowered their price objective on Leidos from $232.00 to $178.00 and set a “buy” rating for the company in a research note on Thursday, May 7th. Wells Fargo & Company started coverage on Leidos in a research note on Wednesday, April 1st. They set an “equal weight” rating and a $165.00 price objective for the company. Finally, Jefferies Financial Group set a $185.00 target price on Leidos in a research report on Wednesday, April 8th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and six have given a Hold rating to the stock. According to MarketBeat, Leidos presently has an average rating of “Moderate Buy” and a consensus target price of $193.64.
Get Our Latest Stock Analysis on LDOS
Leidos Price Performance
Leidos (NYSE:LDOS – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The aerospace company reported $3.13 earnings per share for the quarter, beating analysts’ consensus estimates of $2.88 by $0.25. Leidos had a return on equity of 31.92% and a net margin of 8.15%.The firm had revenue of $4.40 billion during the quarter, compared to analyst estimates of $4.28 billion. During the same quarter last year, the firm earned $2.97 EPS. Leidos’s quarterly revenue was up 3.7% on a year-over-year basis. Leidos has set its FY 2026 guidance at 12.100-12.500 EPS. On average, equities analysts predict that Leidos will post 12.25 earnings per share for the current fiscal year.
Insider Activity at Leidos
In related news, insider Elizabeth A. Porter sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price of $158.78, for a total value of $317,560.00. Following the sale, the insider owned 49,476 shares of the company’s stock, valued at approximately $7,855,799.28. This trade represents a 3.89% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Stephen May sold 1,484 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $132.75, for a total value of $197,001.00. Following the completion of the sale, the director directly owned 10,137 shares in the company, valued at approximately $1,345,686.75. This trade represents a 12.77% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.77% of the stock is currently owned by company insiders.
Institutional Trading of Leidos
Several hedge funds have recently made changes to their positions in the stock. OMERS ADMINISTRATION Corp lifted its holdings in shares of Leidos by 3.0% in the 1st quarter. OMERS ADMINISTRATION Corp now owns 5,601 shares of the aerospace company’s stock worth $871,000 after purchasing an additional 163 shares during the last quarter. Bradley Foster & Sargent Inc. CT raised its stake in Leidos by 19.5% during the 1st quarter. Bradley Foster & Sargent Inc. CT now owns 4,454 shares of the aerospace company’s stock valued at $693,000 after acquiring an additional 727 shares in the last quarter. Waverly Advisors LLC raised its stake in Leidos by 118.0% during the 1st quarter. Waverly Advisors LLC now owns 3,581 shares of the aerospace company’s stock valued at $557,000 after acquiring an additional 1,938 shares in the last quarter. Entropy Technologies LP bought a new stake in Leidos during the 1st quarter valued at $3,199,000. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its stake in Leidos by 6.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 8,033 shares of the aerospace company’s stock valued at $1,249,000 after acquiring an additional 479 shares in the last quarter. Institutional investors own 76.12% of the company’s stock.
About Leidos
Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.
Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.
Further Reading
- Five stocks we like better than Leidos
- Robinhood, SoFi, and Webull Are Telling Very Different Stories
- As Broadcom Eclipses $2 Trillion, Private Credit Giants Wants In
- Target the Red-Hot Spin-Off and Merger Space With These ETFs
- Samsung Joins the $1 Trillion Club as AI Memory Demand Explodes
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.
